These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1351887)
1. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate. Gilligan DM; Stewart R; Chan WL; Oakley CM Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction. Pouleur H; Hanet C; Rousseau MF Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587 [TBL] [Abstract][Full Text] [Related]
3. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course. McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047 [TBL] [Abstract][Full Text] [Related]
4. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure. Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946 [TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of xamoterol in idiopathic dilated cardiomyopathy. Watanabe K; Hirokawa Y; Suzuki K; Shibata A Jpn Heart J; 1988 Sep; 29(5):603-15. PubMed ID: 2975712 [TBL] [Abstract][Full Text] [Related]
6. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest. Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease. Pouleur H; van Eyll C; Hanet C; Cheron P; Charlier AA; Rousseau MF Circulation; 1988 May; 77(5):1081-9. PubMed ID: 2896076 [TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function. Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264 [TBL] [Abstract][Full Text] [Related]
9. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes. Watanabe K; Hirokawa Y; Shibata A J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation. Lundström T; Moor E; Rydén L Am Heart J; 1992 Oct; 124(4):917-23. PubMed ID: 1356311 [TBL] [Abstract][Full Text] [Related]
11. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. Lammers JW; Müller ME; Folgering HT; van Herwaarden CL Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680 [TBL] [Abstract][Full Text] [Related]
12. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure. Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587 [TBL] [Abstract][Full Text] [Related]
13. The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease. Molajo AO; Bennett DH; Marlow HF; Snow HM; Bastain W Br J Clin Pharmacol; 1987 Sep; 24(3):373-9. PubMed ID: 2889460 [TBL] [Abstract][Full Text] [Related]
14. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris. Barrios L; Geboers J; Piessens JH; de Geest H Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055 [TBL] [Abstract][Full Text] [Related]
15. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol. Erlemeier HH; Kupper W; Bleifeld W Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569 [TBL] [Abstract][Full Text] [Related]
16. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure. Virk SJ; Davies MK Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250 [TBL] [Abstract][Full Text] [Related]
17. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure]. Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820 [No Abstract] [Full Text] [Related]
18. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status. Heng MK Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783 [TBL] [Abstract][Full Text] [Related]
19. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430 [TBL] [Abstract][Full Text] [Related]
20. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure. Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]